Stifel lowered the firm’s price target on Accolade to $13 from $15 and keeps a Buy rating on the shares ahead of the company’s Q4 report due after market close on April 25. The firm expects the company to reiterate FY25 revenue and EBITDA guidance, telling investors that assuming a relatively stable economic backdrop, its bottoms-up analysis suggests FY25 guidance is “reasonable, if not beatable.”